• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰变加速因子存在于阵发性夜间血红蛋白尿症红细胞祖细胞上,并在体外红细胞生成过程中丢失。

Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro.

作者信息

Moore J G, Frank M M, Müller-Eberhard H J, Young N S

出版信息

J Exp Med. 1985 Oct 1;162(4):1182-92. doi: 10.1084/jem.162.4.1182.

DOI:10.1084/jem.162.4.1182
PMID:2413153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2187865/
Abstract

A glycoprotein that regulates the deposition of C3b on the erythrocyte surface, called decay-accelerating factor or DAF, is absent from the red blood cells (RBC) of patients with paroxysmal nocturnal hemoglobinuria (PNH), explaining in part their abnormal sensitivity to complement. We used a specific antiserum to DAF, flow microfluorometry, and clonogenic assays for erythroid progenitor cells to study PNH erythropoiesis in vitro. By fluorescence-activated cell sorter analysis, all RBC from normal individuals are DAF+. In contrast, the RBC of six patients with PNH showed discrete populations of DAF- cells (10-44%; x +/- SEM = 31 +/- 6%). The DAF- RBC population was partly eliminated by prior acidified serum lysis. To determine whether erythropoietic progenitors expressed DAF, bone marrow cells were sorted by flow microfluorometry and the separated DAF+ and DAF- populations then cultured in vitro. In two normal individuals, but also in six patients with PNH, erythroid colonies formed only from cells in the DAF+ fraction. However, a variable proportion of the normoblast progeny of these DAF+ progenitor cells from patients with PNH was DAF-. Individual bursts removed from cultures of PNH bone marrow showed two discrete populations by fluorescence; the majority of normoblasts were DAF-, only 3 of 27 individual bursts had greater than 50% DAF+ cells, and in three patients, DAF- normoblasts averaged 79%. In contrast, the progeny of individual bursts from normal individuals comprised a unimodal DAF+ population. In each PNH patient, one normal burst (greater than 80% DAF+ normoblasts) was detected, possibly reflecting a normal residual population of erythroid progenitors. By the criterion of DAF expression, there was no evidence of separate populations of normal and PNH type progenitor cells. The phenotypically normal erythroid progenitors of PNH bone marrow acquire the PNH characteristics during differentiation in vitro.

摘要

一种调节C3b在红细胞表面沉积的糖蛋白,称为衰变加速因子或DAF,在阵发性夜间血红蛋白尿(PNH)患者的红细胞(RBC)中缺失,这部分解释了他们对补体的异常敏感性。我们使用针对DAF的特异性抗血清、流式微量荧光测定法以及红系祖细胞的克隆形成试验来体外研究PNH的红细胞生成。通过荧光激活细胞分选仪分析,正常个体的所有红细胞均为DAF阳性。相比之下,6例PNH患者的红细胞显示出离散的DAF阴性细胞群体(10% - 44%;x ± SEM = 31 ± 6%)。DAF阴性红细胞群体可通过预先的酸化血清裂解部分消除。为了确定红系祖细胞是否表达DAF,通过流式微量荧光测定法对骨髓细胞进行分选,然后将分离出的DAF阳性和DAF阴性群体进行体外培养。在2名正常个体以及6例PNH患者中,红系集落仅由DAF阳性部分的细胞形成。然而,这些来自PNH患者的DAF阳性祖细胞的晚幼红细胞后代中,有可变比例为DAF阴性。从PNH骨髓培养物中取出的单个集落通过荧光显示出两个离散群体;大多数晚幼红细胞为DAF阴性,27个单个集落中只有3个的DAF阳性细胞大于50%,并且在3例患者中,DAF阴性晚幼红细胞平均占79%。相比之下,正常个体单个集落的后代构成单峰DAF阳性群体。在每例PNH患者中,都检测到一个正常集落(大于80%的DAF阳性晚幼红细胞),这可能反映了红系祖细胞的正常残余群体。根据DAF表达的标准,没有证据表明存在正常和PNH型祖细胞的单独群体。PNH骨髓中表型正常的红系祖细胞在体外分化过程中获得了PNH特征。

相似文献

1
Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro.衰变加速因子存在于阵发性夜间血红蛋白尿症红细胞祖细胞上,并在体外红细胞生成过程中丢失。
J Exp Med. 1985 Oct 1;162(4):1182-92. doi: 10.1084/jem.162.4.1182.
2
Expression of decay-accelerating factor on hematopoietic progenitors and their progeny cells grown in cultures with fractionated bone marrow cells from normal individuals and patients with paroxysmal nocturnal hemoglobinuria.衰变加速因子在正常个体和阵发性夜间血红蛋白尿患者的分级骨髓细胞培养的造血祖细胞及其子代细胞上的表达。
Exp Hematol. 1990 Nov;18(10):1132-6.
3
Different distribution of decay-accelerating factor on hematopoietic progenitors from normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
Blood. 1988 Aug;72(2):507-11.
4
Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.正常个体及阵发性夜间血红蛋白尿患者外周血中衰变加速因子的分布
J Exp Med. 1985 Jul 1;162(1):75-92. doi: 10.1084/jem.162.1.75.
5
Characterization of the hematopoietic defect in paroxysmal nocturnal hemoglobinuria.阵发性夜间血红蛋白尿造血缺陷的特征
Exp Hematol. 1986 Mar;14(3):222-9.
6
Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum.阵发性夜间血红蛋白尿症红细胞在酸化血清中溶血易感性增强的分子基础。
Blood. 1991 Aug 1;78(3):820-9.
7
Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.阵发性夜间血红蛋白尿症红细胞中衰变加速因子缺乏、乙酰胆碱酯酶活性降低与末端补体途径限制缺陷之间的关系。
J Clin Invest. 1987 Jul;80(1):165-74. doi: 10.1172/JCI113043.
8
Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.C5b-9对阵发性夜间血红蛋白尿红细胞的反应性溶解增强并不涉及C7结合增加或细胞结合的C3b增加。
J Immunol. 1985 Jan;134(1):506-11.
9
Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.衰变加速因子改善阵发性夜间血红蛋白尿的溶解异常
Proc Natl Acad Sci U S A. 1985 May;82(9):2980-4. doi: 10.1073/pnas.82.9.2980.
10
[Immunocytochemical staining of decay-accelerating factor (DAF) on erythrocytes: paroxysmal nocturnal hemoglobinuria (PNH)].红细胞衰变加速因子(DAF)的免疫细胞化学染色:阵发性夜间血红蛋白尿(PNH)
Rinsho Ketsueki. 1992 Feb;33(2):162-6.

引用本文的文献

1
Reconstitution of the alternative pathway of the complement system enables rapid delineation of the mechanism of action of novel inhibitors.补体系统替代途径的重建使得新型抑制剂作用机制的快速阐明成为可能。
J Biol Chem. 2024 Jul;300(7):107467. doi: 10.1016/j.jbc.2024.107467. Epub 2024 Jun 12.
2
Proliferative capacity of single isolated CD34+ hematopoietic stem/progenitor cells in paroxysmal nocturnal hemoglobinuria.阵发性夜间血红蛋白尿中单个分离的CD34+造血干/祖细胞的增殖能力
Int J Hematol. 2001 Jul;74(1):42-52. doi: 10.1007/BF02982548.
3
Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.临床阵发性夜间血红蛋白尿是造血功能不足情况下糖基磷脂酰肌醇锚定蛋白缺陷克隆扩增的结果。
Int J Hematol. 2001 Jan;73(1):64-70. doi: 10.1007/BF02981904.
4
Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.获得性免疫缺陷综合征不同风险组同性恋男性的红细胞C3b受体表达、免疫复合物及补体激活的改变
J Clin Invest. 1986 Oct;78(4):977-82. doi: 10.1172/JCI112688.
5
Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.阵发性夜间血红蛋白尿症红细胞中衰变加速因子缺乏、乙酰胆碱酯酶活性降低与末端补体途径限制缺陷之间的关系。
J Clin Invest. 1987 Jul;80(1):165-74. doi: 10.1172/JCI113043.
6
Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.阵发性夜间血红蛋白尿中同源限制因子的缺乏
J Exp Med. 1987 Feb 1;165(2):572-7. doi: 10.1084/jem.165.2.572.
7
[Paroxysmal nocturnal hemoglobinuria].[阵发性夜间血红蛋白尿]
Klin Wochenschr. 1990 Mar 5;68(5):247-55. doi: 10.1007/BF02116052.

本文引用的文献

1
Paroxysmal nocturnal hemoglobinuria--present status and future prospects.阵发性夜间血红蛋白尿——现状与未来展望
West J Med. 1980 Mar;132(3):219-28.
2
Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.当与阵发性夜间血红蛋白尿症的红细胞结合时,替代途径转化酶的酶活性增加。
J Clin Invest. 1982 Feb;69(2):337-46. doi: 10.1172/jci110457.
3
Increased sensitivity to complement of erythroid and myeloid progenitors in paroxysmal nocturnal hemoglobinuria.阵发性夜间血红蛋白尿中红系和髓系祖细胞对补体的敏感性增加。
N Engl J Med. 1983 Sep 22;309(12):690-3. doi: 10.1056/NEJM198309223091202.
4
Individual BFU-E in polycythemia vera produce both erythropoietin dependent and independent progeny.
Blood. 1983 May;61(5):876-84.
5
Complement receptors.补体受体
Clin Immunol Rev. 1981;1(4):471-545.
6
Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.阵发性夜间血红蛋白尿患者的受累红细胞缺乏补体调节蛋白衰变加速因子。
Proc Natl Acad Sci U S A. 1983 Aug;80(16):5066-70. doi: 10.1073/pnas.80.16.5066.
7
Changes in cell surface antigen expression during hemopoietic differentiation.造血分化过程中细胞表面抗原表达的变化。
Blood. 1982 Sep;60(3):703-13.
8
Complement ligand-receptor interactions that mediate biological responses.介导生物反应的补体配体-受体相互作用。
Annu Rev Immunol. 1983;1:243-71. doi: 10.1146/annurev.iy.01.040183.001331.
9
Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.阵发性夜间血红蛋白尿中具有补体调节活性的红细胞膜蛋白缺乏。
Proc Natl Acad Sci U S A. 1983 Sep;80(17):5430-4. doi: 10.1073/pnas.80.17.5430.
10
Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.阵发性夜间血红蛋白尿:异常红细胞中类似补体因子H功能的缺陷。
J Exp Med. 1983 Jun 1;157(6):1971-80. doi: 10.1084/jem.157.6.1971.